The 2018 National Cancer Research Institute (NCRI) Cancer Conference was held in Glasgow, UK, from the 4–6 November. Follow this page for expert interviews and stay up-to-date as breakthrough clinical trial results for oncolytic viruses are discussed, pressing issues on treatment challenges are explored and promising evidence for emerging biomarkers presented.

NCRI 2018

01–04 November 2018 | Glasgow, UK

NCRI 2018

01–04 November 2018 | Glasgow, UK

The 2018 National Cancer Research Institute (NCRI) Cancer Conference was held in Glasgow, UK, from the 4–6 November. Follow this page for expert interviews and stay up-to-date as breakthrough clinical trial results for oncolytic viruses are discussed, pressing issues on treatment challenges are explored and promising evidence for emerging biomarkers presented.

New thyroid cancer trials: questioning ablative radioiodine and exploring resensitization 1:33
New thyroid cancer trials: questioning ablative radioiodine and exploring resensitization
Jonathan Wadsley
Head and neck cancer challenges & cetuximab trial updates 3:28
Head and neck cancer challenges & cetuximab trial updates
Quynh-Thu Le
Improving glioma surgery using a real time fluorescence biomarker 2:37
Improving glioma surgery using a real time fluorescence biomarker
Kathreena Kurian
Incorporating patients into the treatment decision making process 3:05
Incorporating patients into the treatment decision making process
Adrian Edwards
Improving cancer research via involving ‘consumers’ 1:45
Improving cancer research via involving ‘consumers’
Richard Stephens
Addressing drug resistance and unresponsiveness in melanoma 1:05
Addressing drug resistance and unresponsiveness in melanoma
Richard White
Living with and beyond cancer 1:25
Living with and beyond cancer
Richard Stephens
Immunotherapeutic landscape for head and neck cancer 2:36
Immunotherapeutic landscape for head and neck cancer
Quynh-Thu Le
Glioma biomarker research 1:35
Glioma biomarker research
Kathreena Kurian
A commonly used molecular cancer imaging technique 1:58
A commonly used molecular cancer imaging technique
Sanjiv Gambhir
Adipocytes in the tumor microenvironment: an emerging target for melanoma treatment 3:13
Adipocytes in the tumor microenvironment: an emerging target for melanoma treatment
Richard White
The NCRI: supporting and expediting UK cancer research 2:00
The NCRI: supporting and expediting UK cancer research
Richard Stephens
Molecular imaging to determine the efficacy of immunotherapy 3:35
Molecular imaging to determine the efficacy of immunotherapy
Sanjiv Gambhir
HiLo: low risk thyroid cancer can be treated with lower doses of radiation 3:21
HiLo: low risk thyroid cancer can be treated with lower doses of radiation
Jonathan Wadsley
Patient involvement in decision making requires further exploration 1:12
Patient involvement in decision making requires further exploration
Adrian Edwards
IO-chemo and IO-radio options for cancer treatment 2:31
IO-chemo and IO-radio options for cancer treatment
John Bell
The content of VJOncology is intended for healthcare professionals